Search details
1.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31787526
2.
Mantle cell lymphoma may have a different clinical course in Mexican Mestizos: Real-world data from a single center.
Rev Invest Clin
; 73(5)2020 Oct 19.
Article
in English
| MEDLINE | ID: mdl-33075042
3.
Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome.
Clin Endocrinol (Oxf)
; 90(1): 155-161, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30281805
4.
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies.
Gynecol Oncol
; 154(1): 199-206, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30987772
5.
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
Breast Cancer Res
; 20(1): 52, 2018 06 14.
Article
in English
| MEDLINE | ID: mdl-29898752
6.
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
Cancer
; 124(8): 1710-1721, 2018 04 15.
Article
in English
| MEDLINE | ID: mdl-29360160
7.
Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.
Pharmacogenet Genomics
; 27(10): 378-385, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28763429
8.
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Oncologist
; 22(7): 834-842, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28495808
9.
Prevalence of BCL-2/J(H) Translocation in Healthy African Americans.
Ann Hematol
; 96(1): 51-55, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27730341
10.
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers.
Gynecol Oncol
; 146(1): 64-68, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28461031
11.
Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.
Cancer
; 122(4): 618-25, 2016 Feb 15.
Article
in English
| MEDLINE | ID: mdl-26565660
12.
Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
J Transl Med
; 14(1): 129, 2016 05 10.
Article
in English
| MEDLINE | ID: mdl-27165126
13.
Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas.
Acta Oncol
; 59(9): 1024-1027, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32672484
14.
High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case report.
Hered Cancer Clin Pract
; 13(1): 6, 2015.
Article
in English
| MEDLINE | ID: mdl-25649062
15.
Dual HER2 blockade: preclinical and clinical data.
Breast Cancer Res
; 16(4): 419, 2014 Aug 01.
Article
in English
| MEDLINE | ID: mdl-25928889
16.
The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.
Br J Haematol
; 165(1): 78-88, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24467634
17.
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.
Breast Cancer Res Treat
; 138(2): 427-35, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23479422
18.
Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review.
Cancer Med
; 12(8): 9434-9438, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36806695
19.
Trends in participant race and sex reporting in lung cancer phase III clinical trials.
Cancer Rep (Hoboken)
; 6 Suppl 1: e1856, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37421166
20.
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial.
Front Oncol
; 13: 1139347, 2023.
Article
in English
| MEDLINE | ID: mdl-37305569